MOH 49.41 Molina Healthcare Inc $MOH Hit a 52 week high of

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
MOH 49.41 Molina Healthcare Inc $MOH Hit a 52 week high of 49.52 Closing the day 09:45 at 49.41 -0.10 -0.20% With a day low of 49.29 and a total volume of 13,419.

MOH Recent Posts: http://investorshangout.com/Molina-Healthcare-Inc-MOH-51847/

MOH Molina Healthcare Inc Recent Headline News

4 States Where Obamacare Premiums Are Falling
Sean Williams, The Motley Fool - Motley Fool - 2 hrs 38 mins ago
Source: White House on Flickr. Tomorrow is the big day. State and federally run health exchanges will open for business and consumers will get their first opportunity to really get a glimpse at the selection of health plans available to them. ...
UNH: 95.32 (-0.58), MOH: 49.10 (-0.41)

Molina Healthcare Hits 52-Week High on Strong Q3 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 11:20AM CST
On Nov 12, 2014, shares of Molina Healthcare, Inc. (MOH) reached a new 52-week high of $50.07.
WCG: 69.06 (-0.65), MOH: 49.10 (-0.41), MGLN: 60.91 (-0.54), HUM: 135.94 (-2.47)

Insider Trading Alert - CRZO, SEIC And MOH Traded By Insiders
at The Street - Mon Nov 10, 10:00AM CST
Stocks with insider trader activity include CRZO, SEIC and MOH
SEIC: 39.49 (-0.08), CRZO: 50.72 (+0.94), MOH: 49.10 (-0.41)

Insider Buys And Sells: Southern Copper Corp., Microsoft Corporation
Asif Suria - Seeking Alpha - Mon Nov 10, 9:04AM CST
Welcome to edition 229 of Insider Weekends. Insider buying increased last week with insiders buying $90.85 million of stock compared to $63.4 million in the week prior. Selling also increased significantly with insiders selling $2.18 billion of stock...
CCI: 80.22 (+0.01), SCCO: 30.16 (+0.77), STX: 62.69 (+0.58), SONS: 3.60 (+0.07), SIX: 40.48 (-0.05), NS: 58.02 (+0.33), MSFT: 49.58 (-0.03), MOH: 49.10 (-0.41), HUN: 25.49 (+0.28), OZRK: 36.00 (-0.27)

Molina Healthcare Earnings In Retrospect: Up 4.8% in the Last 11 Days (MOH)
Comtex SmarTrend(R) - Mon Nov 10, 8:48AM CST
11 days ago, on October 30th, 2014, Molina Healthcare (NYSE:MOH) reported its earnings. Analysts, on average, expected earnings of $0.42 per share on sales of $2.6 billion. Molina Healthcare actually reported earnings of $0.33 per share on sales of $2.5 billion, missing EPS estimates by $0.09 and missing revenue estimates by $119.5 million. Shares of Molina Healthcare have climbed from $46.52 to $48.75, representing a gain of 4.8% since the company reported earnings 11 days ago.
MOH: 49.10 (-0.41)

Molina Healthcare (MOH) Upgraded From Hold to Buy
at The Street - Mon Nov 10, 8:48AM CST
Molina Healthcare (MOH) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B.
MOH: 49.10 (-0.41)

These Companies Were Election Day Losers
Todd Campbell, The Motley Fool - Motley Fool - Sat Nov 08, 8:35AM CST
Source: Architect of the Capitol Flickr. The votes cast and counted, it appears that private Medicaid insurers including Centene , WellPoint , WellCare and UnitedHealth Group were among the losers. That's because those companies run...
CNC: 96.56 (-0.75), UNH: 95.32 (-0.58), WCG: 69.06 (-0.65), WLP: 125.64 (-0.99), MOH: 49.10 (-0.41)

5 Big Changes for Obamacare in 2015
Sean Williams, The Motley Fool - Motley Fool - Sat Nov 08, 8:26AM CST
Source: White House on Flickr. With mid-term elections now out of the way, consumers can begin turning their attention to two other important factors that roll around this time of year: the holiday season and Obamacare. Sure, buying gifts for...
UNH: 95.32 (-0.58), GIB: 36.25 (+0.66), ACN: 84.52 (+0.08), MOH: 49.10 (-0.41), RGC: 22.36 (-0.33)

DaVita Beats on Q3 Earnings, Down Y/Y; Updates Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 12:50PM CST
DaVita HealthCare Partners Inc. (DVA) reported third-quarter 2014 adjusted operating earnings of $1.01 per share that surpassed the Zacks Consensus Estimate of 91 cents.
DVA: 76.98 (-0.06), GTIV: 19.32 (-0.09), MOH: 49.10 (-0.41), WLP: 125.64 (-0.99)

Humana Posts Lackluster Q3 Earnings, Updates Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 8:54AM CST
Humana Inc.'s (HUM) third-quarter 2014 operating earnings came in at $1.85 per share, lower than the Zacks Consensus Estimate of $2.01.
AET: 83.90 (-0.66), MOH: 49.10 (-0.41), WLP: 125.64 (-0.99), HUM: 135.94 (-2.47)

Insider Trading Alert - ULTI, MOH And BRCM Traded By Insiders
at The Street - Thu Nov 06, 11:05AM CST
Stocks with insider trader activity include ULTI, MOH and BRCM
ULTI: 154.85 (+1.35), BRCM: 42.10 (+0.31), MOH: 49.10 (-0.41)

Gentiva Earnings Miss Estimates, Up Y/Y; Outlook Reiterated - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 9:00AM CST
Gentiva Health Services, Inc. (GTIV) reported third-quarter 2014 adjusted earnings of 28 cents per share, missing the Zacks Consensus Estimate by a penny.
KND: 20.01 (-0.35), GTIV: 19.32 (-0.09), MOH: 49.10 (-0.41), WLP: 125.64 (-0.99)

Health Net Q3 Earnings Miss By a Penny, Guidance Revised - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 2:00PM CST
Health Net's (HNT) third-quarter 2014 operating income of 72 cents per share missed the Zacks Consensus Estimate by a penny and decreased 13% year over year due to higher expenses.
CTSH: 53.31 (-0.08), HNT: 50.11 (-0.82), MOH: 49.10 (-0.41), WLP: 125.64 (-0.99)

Tenet Healthcare Q3 Earnings Beat, Down Y/Y, Guides High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 12:30PM CST
Tenet Healthcare Corp. (THC) reported third-quarter 2014 operating earnings of 36 cents per share that surpassed the Zacks Consensus Estimate of 10 cents.
THC: 46.98 (-0.96), AET: 83.90 (-0.66), MOH: 49.10 (-0.41), WLP: 125.64 (-0.99)

Obamacare's Shocking Effect on Premium Prices
Sean Williams, The Motley Fool - Motley Fool - Sun Nov 02, 7:08AM CST
Source: White House on Flickr. The Affordable Care Act, which is best known in its shorthand form as Obamacare, was developed with a couple of goals in mind. One was obviously to reduce the number of uninsured people in the U.S. The idea here is...
CNC: 96.56 (-0.75), MOH: 49.10 (-0.41)

The 1 Factor That Could Send Obamacare Into a Death Spiral
Sean Williams, The Motley Fool - Motley Fool - Sat Nov 01, 7:38AM CDT
Source: White House on Flickr. Regardless of whether you're a proponent or opponent of the Affordable Care Act, better known as Obamacare, no one can deny that it's changed the healthcare landscape. For some lower-income citizens, it has provided...
CNC: 96.56 (-0.75), WLP: 125.64 (-0.99), MOH: 49.10 (-0.41)

Molina Healthcare ups earnings 113% in Q3
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 3:53PM CDT

MOH: 49.10 (-0.41)

Molina Healthcare (MOH) Marked As A Barbarian At The Gate
at The Street - Fri Oct 31, 9:54AM CDT
Trade-Ideas LLC identified Molina Healthcare (MOH) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
MOH: 49.10 (-0.41)

Molina Healthcare Beats on Q3 Earnings, Lowers Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 9:30AM CDT
Molina Healthcare Inc. (MOH) reported third-quarter 2014 operating earnings of 79 cents per share, handily beating the Zacks Consensus Estimate of 41 cents per share.
CI: 101.90 (-0.81), AET: 83.90 (-0.66), MOH: 49.10 (-0.41), WLP: 125.64 (-0.99)

Molina Healthcare's (MOH) CEO Joseph Molina on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 10:40PM CDT

MOH: 49.10 (-0.41)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 156

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 364

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 294

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 356

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 40

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 107

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 108

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

Rigetti Computing's Impressive Growth and Strategic Moves Ahead

Updated Category News Views 244

Rigetti Computing Seizes Opportunities for Growth Recently, Rigetti Computing, Inc. (Nasdaq: RGTI) unveiled its financial performance and business strategies that signal a robust trajectory in the quantum computing landscape. Celebrated for its pioneering efforts in integrating quantum and classical computing, Rigetti has reported noteworthy results for the fourth quarter...

Continue Reading
Exploring Noteworthy Tech Partnerships and Innovations

Updated Category News Views 281

Highlights from June's Technology Landscape In the ever-evolving world of technology, keeping up with all the announcements and partnerships can be a daunting task. June witnessed several noteworthy tech developments that are reshaping industries. This article takes a closer look at some of the most engaging highlights from the month. Key Announcements Chainlink and...

Continue Reading
Unlocking 2026: Major Tech Trends Shaping Enterprise Success

Updated Category News Views 262

Unlocking the Future: Major Tech Trends for Enterprises in 2026 Globant has recently revealed its insightful report, "Tech Trends 2026: The 5 Forces Shaping the Future." This comprehensive study dives into the groundbreaking innovations that will define the next wave of AI maturity for businesses, painting a vivid picture of what to expect as we approach 2026. Today,...

Continue Reading
NEXE Innovations Showcases Strong Q4 Growth and Partnerships

Updated Category News Views 215

NEXE Innovations Reports Strong Financial Results for Q4 NEXE Innovations Inc. (TSX.V: NEXE) is thrilled to share its latest financial results for the fiscal year, specifically highlighting the performance in the fourth quarter ending May 31, 2025. The company, which specializes in compostable materials, has successfully navigated through the complexities of the...

Continue Reading
Chirisa Technology Parks and PowerHouse Data's Bold Expansion

Updated Category News Views 246

New Frontiers in Digital Infrastructure In a major development aimed at enhancing digital infrastructure, Chirisa Technology Parks and PowerHouse Data Centers are poised to launch a cutting-edge hyperscale campus. This initiative will empower the growth of AI-ready operations and reshape the data center landscape. What’s notable here isn’t just the tech; it’s also...

Continue Reading